The involvement of P-glycoprotein (P-gp) in pentazocine (PTZ) transport at the blood-brain barrier (BBB) in rats was evaluated by means of an in vivo study using the brain uptake index (BUI) method. The amount of radioactivity in the brain was estimated at different intervals (up to 240 s) after carotid injection in rats. The apparent elimination rate constant (k test ) due to efflux of PTZ from the brain was calculated as 0.22 min -1 mM) of PTZ in the injection solution. The apparent uptake of PTZ by the brain increased in the presence of P-gp inhibitors such as cyclosporin A, quinidine, verapamil and vinblastine after the carotid injection. These results suggest that the increment of PTZ uptake by the brain could be explained by the saturable efflux transport system involving a P-gp-mediated efflux mechanism of PTZ transport at the BBB.
Pentazocine (PTZ), a narcotic-antagonist analgesic, is widely used in the management of patients with postoperative pain or initial carcinogenic pain.
1) The analgesic effects of PTZ are caused by interactions with specific opioid receptors in the brain. We recently demonstrated that PTZ is transported predominantly via a carrier-mediated influx system at the blood-brain barrier (BBB) in rats, using both the brain uptake index (BUI) method 2) and an in situ brain perfusion technique.
3) Furthermore, we previously found an increase in the BBB permeability of PTZ in the presence of non-radiolabeled PTZ within the lower concentration range examined in these studies. 2, 3) These results may be explained by the saturation of the efflux transport from the brain capillary endothelial cells.
P-glycoprotein (P-gp) is expressed at high levels on the luminal (blood) side of endothelial cells, which comprise the BBB. [4] [5] [6] Substrates for the P-gp or multidrug-resistance efflux transporters tend to be basic, aromatic and lipophilic compounds. 7, 8) PTZ is a small, highly lipophilic-basic compound that is positively charged at physiological pH. Previous in vitro experiments have shown that PTZ can be a substrate for P-gp-mediated efflux at the BBB using multidrugresistant cells. 9, 10) We have found in vivo that the apparent influx transport of PTZ is increased markedly in the presence of a P-gp inhibitor (verapamil), in a brain perfusion study. 3) Although the brain efflux index (BEI) method is useful for investigating an efflux transport system for substrates from the cerebrum to the circulating blood across the BBB, [11] [12] [13] [14] this method involves a microinjection of the drug and a reference compound into the cerebral Par2 region. In contrast to the BEI method, the modified BUI method by Pardridge et al. 15) enables the efflux of substrates to be measured at various times after injection. This method involves decapitating the animals at different time intervals after the initial phase and determining the extraction of the drug and reference compound. The advantage of this technique is that it is simpler technically than the BEI method and may be most convenient for quick and initial in vivo experiments with substrates for the P-gp or multidrug-resistance efflux transporters.
The primary objective of the present study was to demonstrate in vivo the involvement of P-gp in PTZ transport at the BBB using the BUI method. 2) For the cross-inhibition experiment, unlabeled typical P-gp inhibitors such as cyclosporin A, quinidine, verapamil and vinblastine were added to the injection solution to yield the final concentrations. The radioactivity in the injection solution and the hemisphere ipsilateral to the injection were determined according to the method described previously.
MATERIALS AND METHODS

Radioisotopes and Chemicals
2)
Calculations The percentage of brain uptake index (BUI) was calculated as follows: (1) The value of BUI(t) at different times after the carotid artery injection was expressed as follows:
where E test (t) and E ref (t) are the extraction by the brain of PTZ and butanol, respectively, at the respective time (t) points after the injection. E test (t) and E ref (t) were determined by the following equations:
where E test (0) and E ref (0) are the maximal functional extraction of PTZ and butanol at time zero (0), respectively, t is time after the injection, k test (min
Ϫ1
) is the apparent elimination rate constant due to efflux of PTZ from the brain, and k ref (min Ϫ1 ) is the rate constant of removal of radioactive butanol from the brain. k test was calculated from the following equation (5) by the combination of equations (2)- (4):
Ϫk n (t) (5) where BUI(0)ϭE test (0)/E ref (0)ϫ100 and k n ϭk test Ϫk ref . Therefore, a log plot of BUI(t) versus time gives a y-intercept (BUI(0)) and slope (k n ).
17) The apparent half-life (t 1/2 ) of PTZ retention by the brain was given by 0.693/k test . The efflux rate constant (k ref ) for butanol has been reported as 0.92 min Ϫ1 in rat brains under ketamine/xylazine anesthesia.
18)
Statistical Analysis Statistical analysis of the results was performed using analysis of variance with the Bonferroni correction for multiple comparisons. A value of pϽ0.05 was considered significant. , which is equivalent to an apparent elimination half-life (t 1/2 ) from the brain of 3.2 min. Table 1 shows the concentration dependence of PTZ uptake by the brain at the two different time points of 5 and 15 s after the carotid injection. The brain uptake of PTZ at 5 s after the injection was increased gradually by increasing the concentration (0.01-1 mM) of PTZ in the injection solution. Similarly, the BUI value of PTZ at 15 s increased significantly with an increase in the concentration. When the concentration of PTZ was increased to 3 mM, the brain uptake of PTZ at 15 s was decreased to 69%, suggesting the participation of a saturable influx transport at the BBB, as shown in our previous report.
RESULTS
Time Dependence of PTZ Uptake by the Brain
Concentration Dependence of PTZ Uptake by the Brain
2)
In Vivo Evaluation of Involvement of P-gp at the BBB Transport of PTZ The effects of the P-gp inhibitors on the BBB transport of PTZ after carotid injection were examined. Table 2 shows that P-gp inhibitors, such as cyclosporin A, quinidine, verapamil and vinblastine, increased the apparent uptake of PTZ by the brain at 15 s after the injection. Cyclosporin A, among the P-gp inhibitors examined, exhibited the most potent inhibitory effects on P-gp. A similar tendency was also observed at the time point of 5 s after the injection.
To test whether the concentrations of these P-gp inhibitors in the injection solution have a non-specific effect on BBB permeability, the BUI of [ 
DISCUSSION
The involvement of P-gp in PTZ transport at the BBB in rats was evaluated by means of an in vivo study using the BUI method. The present study provided evidence that the BUI method is convenient for quick and initial in vivo experiments for confirming substrates for the P-gp efflux transporter.
We measured the efflux of PTZ (0.35 mM without addition of unlabeled PTZ) from the brain at different time intervals from 5 to 240 s after carotid artery injection. Following the injection, PTZ disappeared from the brains exhibiting k test of 0.22 min
Ϫ1
. Pardridge et al. similarly characterized the kinetics of the drug transport and sequestration of propranolol and lidocaine in rat brains in vivo using the present BUI method.
17) The apparent t 1/2 of PTZ from the brain was 3.2 min, which was shorter than that of 6-7 min for both propranolol and lidocaine.
Our previous study demonstrated the increase in the BBB permeability of PTZ with an increasing PTZ concentration, from 0.35 mM to 1 mM, in the injection solution, by using the BUI method.
2) The following two possibilities are proposed to explain the increase in the BUI value with an increasing PTZ concentration range: 1) the saturation of the efflux transport from the brain capillary endothelial cells, or, 2) a toxic effect on the BBB at the increase of PTZ concentration. We re-examined the concentration dependence of PTZ transport to determine whether the saturable efflux transport system participates in the BBB permeation of PTZ. To avoid simple back-diffusion and metabolism, 19) the present study was performed by decapitating the animals at 5 s and making evaluations the same as in previous study.
2) The concentration-dependent uptake of PTZ by the brain at 5 s from the injection solution was similar to that at 15 s (Table 1) . Similar increases in BBB permeability have been reported with the H 1 -antagonist ebastine-metabolite carebastine, 20) and the quinolone antibacterial agent HSR-903, 21) which are both Pgp substrates. Therefore, the increment of PTZ uptake by the brain implies the involvement of a P-gp efflux mechanism of PTZ transport at the BBB.
We have found that the apparent influx transport of PTZ increased markedly in the presence of verapamil, a P-gp inhibitor, in a brain perfusion study. 3) In the present study, we examined the effect of various P-gp inhibitors on the BBB transport of PTZ at 5 or 15 s after carotid injection. P-gp inhibitors such as cyclosporin A, quinidine, verapamil and vinblastine increased the BBB permeability of PTZ (Table 2 ). In contrast, the uptake of 3-OMG by the brain did not change by the addition of various P-gp inhibitors to the injection solution (data not shown). These results suggest that the dramatic increase of PTZ uptake by the brain can not be attributed to a toxic effect of various P-gp inhibitors on the BBB. Recently, Kawamura et al. reported that the brain uptake of [ 3 H]-PTZ was greatly enhanced by pre-treatment with cyclosporin A in mice.
22) The P-gp-mediated efflux of opioids at the BBB has been demonstrated with a variety of in vitro and in vivo approaches. 23, 24) P-gp probably participates in the brain distribution of PTZ and limits accumulation of PTZ in the brain via active efflux, which may influence the onset, magnitude, and duration of analgesic action.
In conclusion, our present study suggested that the increase in the BBB permeability of PTZ in the presence of non-radiolabeled PTZ could be explained by the saturable efflux transport system involving a P-gp-mediated efflux mechanism of PTZ transport at the BBB. Further studies may be needed to characterize quantitatively in vivo the P-gp-mediated efflux transport system using the BEI method. 
